Gina Lin

669 total citations
10 papers, 458 citations indexed

About

Gina Lin is a scholar working on Infectious Diseases, Pharmacology and Virology. According to data from OpenAlex, Gina Lin has authored 10 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Pharmacology and 3 papers in Virology. Recurrent topics in Gina Lin's work include HIV Research and Treatment (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Gina Lin is often cited by papers focused on HIV Research and Treatment (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Gina Lin collaborates with scholars based in United States, France and United Kingdom. Gina Lin's co-authors include Elizabeth G. Rhee, Christopher Bruno, Nobuaki Shime, Jennifer A. Huntington, Álvaro Réa-Neto, Ignacio Martín‐Loeches, Marin H. Kollef, Joan R. Butterton, Brian Yu and Martin Nováček and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and The Lancet Infectious Diseases.

In The Last Decade

Gina Lin

9 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gina Lin United States 7 199 165 161 149 104 10 458
Silvia Boni Italy 10 207 1.0× 117 0.7× 167 1.0× 148 1.0× 75 0.7× 30 481
Georgios Chrysos Greece 8 99 0.5× 105 0.6× 99 0.6× 49 0.3× 81 0.8× 17 241
Luigi Ronga Italy 12 142 0.7× 73 0.4× 142 0.9× 115 0.8× 29 0.3× 36 356
Elizabeth Castaño Panama 9 48 0.2× 170 1.0× 187 1.2× 77 0.5× 70 0.7× 18 454
Ilaria De Benedetto Italy 9 55 0.3× 124 0.8× 92 0.6× 52 0.3× 42 0.4× 25 274
Annelot F. Schoffelen Netherlands 10 86 0.4× 187 1.1× 112 0.7× 16 0.1× 56 0.5× 26 345
Julia Abernethy United Kingdom 6 102 0.5× 170 1.0× 104 0.6× 9 0.1× 46 0.4× 7 308
Nefise Öztoprak Türkiye 10 74 0.4× 141 0.9× 150 0.9× 29 0.2× 6 0.1× 37 392
Timothy R. Pasquale United States 10 28 0.1× 125 0.8× 80 0.5× 39 0.3× 23 0.2× 16 282
Drew Lewis United States 5 151 0.8× 30 0.2× 145 0.9× 106 0.7× 5 0.0× 10 276

Countries citing papers authored by Gina Lin

Since Specialization
Citations

This map shows the geographic impact of Gina Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gina Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gina Lin more than expected).

Fields of papers citing papers by Gina Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gina Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gina Lin. The network helps show where Gina Lin may publish in the future.

Co-authorship network of co-authors of Gina Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Gina Lin. A scholar is included among the top collaborators of Gina Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gina Lin. Gina Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Gao, Wei, Julie Passarell, Yogesh T. Patel, et al.. (2022). Exposure–Efficacy Analyses Support Optimal Dosing Regimens of Ceftolozane/Tazobactam in Participants with Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia in ASPECT-NP. Antimicrobial Agents and Chemotherapy. 66(5). e0139921–e0139921. 5 indexed citations
3.
Martín‐Loeches, Ignacio, Jean‐François Timsit, Marin H. Kollef, et al.. (2021). Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia. Journal of Antimicrobial Chemotherapy. 77(4). 1166–1177. 15 indexed citations
4.
5.
Kollef, Marin H., Martin Nováček, Álvaro Réa-Neto, et al.. (2019). Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial. The Lancet Infectious Diseases. 19(12). 1299–1311. 230 indexed citations
6.
Lin, Gina, et al.. (2019). Shared right-hemispheric representations of sensorimotor goals in dynamic task environments. Experimental Brain Research. 237(4). 977–987.
7.
8.
Orkin, Chloe, Kathleen Squires, Jean‐Michel Molina, et al.. (2018). LB1. Doravirine/Lamivudine/Tenofovir DF Continues to Be NonInferior to Efavirenz/Emtricitabine/Tenofovir DF in Treatment-Naïve Adults With HIV-1 Infection: Week 96 Results of the DRIVE-AHEAD Trial. Open Forum Infectious Diseases. 5(suppl_1). S759–S759. 9 indexed citations
9.
Dow, Geoffrey S., Jun Liu, Gina Lin, et al.. (2015). Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries. Malaria Journal. 14(1). 473–473. 20 indexed citations
10.
Salvante, Katrina G., Gina Lin, Rosemary L. Walzem, & Tony D. Williams. (2007). Characterization of very-low density lipoprotein particle diameter dynamics in relation to egg production in a passerine bird. Journal of Experimental Biology. 210(6). 1064–1074. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Boni Breakdown of academic impact, for papers by Georgios Chrysos Breakdown of academic impact, for papers by Luigi Ronga Breakdown of academic impact, for papers by Elizabeth Castaño Breakdown of academic impact, for papers by Ilaria De Benedetto Breakdown of academic impact, for papers by Annelot F. Schoffelen Breakdown of academic impact, for papers by Julia Abernethy Breakdown of academic impact, for papers by Nefise Öztoprak Breakdown of academic impact, for papers by Timothy R. Pasquale Breakdown of academic impact, for papers by Drew Lewis
Rankless by CCL
2026